Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
This study has been completed.
Study NCT00433108 Information provided by Antipodean Pharmaceuticals, Inc.
First Received on February 7, 2007. Last Updated on August 12, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C
Additional conditions recognized in this trial
Hepatitis C, Chronic
More general conditions related to this trial
Digestive System Diseases
Hepatitis, Viral, Human
RNA Virus Infections
Interventions listed in this trial
Mitoquinone mesylate (MitoQ)
Sponsors listed in this trial
Antipodean Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers